Brief: Foghorn Therapeutics Q3 EPS USD -0.31
Nov 04 (Reuters) - Foghorn Therapeutics Q3 collaboration revenue USD 7.808 million. * Q3 net income USD -19.122 million
Nov 04 (Reuters) - Foghorn Therapeutics Q3 collaboration revenue USD 7.808 million. * Q3 net income USD -19.122 million